New research publication: First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants|
New research partnership with China Resources Biopharmaceutical
Imbalanced Bispecific Antibodies Bispecific antibodies with computationally optimized differential binding affinities, biochemical and biophysical features, and a common light chain.
3541 Investment Blvd. Suite 3, Hayward, CA 94545 USA